Cx Institutional Amgen Inc Transaction History

Cx Institutional

  • $2.24 Billion
  • Q3 2024

A detailed history of Cx Institutional transactions in Amgen Inc stock. As of the latest transaction made, Cx Institutional holds 40,355 shares of AMGN stock, worth $11.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
40,355
Previous 9,614 319.75%
Holding current value
$11.6 Million
Previous $3 Million 332.97%
% of portfolio
0.58%
Previous 0.14%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$309.38 - $337.38 $9.51 Million - $10.4 Million
30,741 Added 319.75%
40,355 $13 Million
Q2 2024

Jul 11, 2024
SELL
$262.75 - $319.31 $6.61 Million - $8.03 Million
-25,144 Reduced 72.34%
9,614 $3 Million
Q1 2024

Apr 15, 2024
BUY
$268.87 - $324.56 $3.56 Million - $4.3 Million
13,241 Added 61.54%
34,758 $9.88 Million
Q4 2023

Jan 12, 2024
SELL
$255.7 - $288.46 $1.97 Million - $2.22 Million
-7,699 Reduced 26.35%
21,517 $6.2 Million
Q3 2023

Oct 17, 2023
BUY
$218.65 - $271.46 $392,258 - $486,999
1,794 Added 6.54%
29,216 $7.85 Million
Q2 2023

Jul 26, 2023
BUY
$214.27 - $253.37 $85,922 - $101,601
401 Added 1.48%
27,422 $6.09 Million
Q1 2023

May 04, 2023
BUY
$225.79 - $275.2 $1.01 Million - $1.23 Million
4,486 Added 19.91%
27,021 $6.53 Million
Q4 2022

Feb 03, 2023
BUY
$229.03 - $291.01 $552,649 - $702,207
2,413 Added 11.99%
22,535 $5.92 Million
Q3 2022

Nov 04, 2022
BUY
$224.46 - $253.15 $2.09 Million - $2.36 Million
9,320 Added 86.28%
20,122 $4.54 Million
Q2 2022

Aug 02, 2022
SELL
$230.71 - $256.74 $1.78 Million - $1.98 Million
-7,716 Reduced 41.67%
10,802 $2.63 Million
Q1 2022

May 09, 2022
SELL
$219.27 - $242.57 $833,664 - $922,251
-3,802 Reduced 17.03%
18,518 $4.48 Million
Q4 2021

Jan 18, 2022
BUY
$198.88 - $227.6 $1.52 Million - $1.74 Million
7,659 Added 52.24%
22,320 $5.02 Million
Q3 2021

Nov 10, 2021
SELL
$212.27 - $248.7 $60,496 - $70,879
-285 Reduced 1.91%
14,661 $3.12 Million
Q2 2021

Aug 04, 2021
SELL
$233.58 - $259.14 $94,599 - $104,951
-405 Reduced 2.64%
14,946 $3.64 Million
Q1 2021

Apr 15, 2021
SELL
$221.91 - $258.6 $2.36 Million - $2.75 Million
-10,631 Reduced 40.92%
15,351 $3.82 Million
Q4 2020

Jan 12, 2021
SELL
$216.38 - $257.67 $400,735 - $477,204
-1,852 Reduced 6.65%
25,982 $5.97 Million
Q3 2020

Oct 13, 2020
BUY
$234.65 - $260.95 $798,513 - $888,012
3,403 Added 13.93%
27,834 $7.07 Million
Q2 2020

Aug 06, 2020
BUY
$197.81 - $242.74 $267,241 - $327,941
1,351 Added 5.85%
24,431 $5.76 Million
Q1 2020

Apr 29, 2020
BUY
$182.24 - $241.7 $1.22 Million - $1.62 Million
6,716 Added 41.04%
23,080 $4.68 Million
Q4 2019

Jan 21, 2020
BUY
$189.21 - $243.2 $10,217 - $13,132
54 Added 0.33%
16,364 $3.95 Million
Q3 2019

Oct 10, 2019
BUY
$174.11 - $208.62 $650,126 - $778,987
3,734 Added 29.69%
16,310 $3.16 Million
Q2 2019

Jul 17, 2019
BUY
$166.7 - $195.41 $1.07 Million - $1.25 Million
6,390 Added 103.3%
12,576 $2.32 Million
Q1 2019

Apr 03, 2019
SELL
$180.87 - $203.88 $180 - $203
-1 Reduced 0.02%
6,186 $1.18 Million
Q4 2018

Jan 14, 2019
SELL
$178.4 - $208.25 $205,873 - $240,320
-1,154 Reduced 15.72%
6,187 $1.2 Million
Q3 2018

Oct 09, 2018
BUY
$185.29 - $208.89 $53,363 - $60,160
288 Added 4.08%
7,341 $1.52 Million
Q2 2018

Jul 12, 2018
BUY
$166.05 - $186.51 $365,808 - $410,881
2,203 Added 45.42%
7,053 $1.3 Million
Q2 2018

Jul 12, 2018
BUY
$166.05 - $186.51 $805,342 - $904,573
4,850 New
4,850 $827,000

Others Institutions Holding AMGN

# of Institutions
3,121
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email